Table 1:
Characteristic | Placebo (N = 24) | IMGX003 (N = 26) | All Patients (N = 50) |
---|---|---|---|
| |||
Age at Baseline (years) | |||
n | 24 | 26 | 50 |
Mean (SD) | 45.0 (13.88) | 42.7 (10.88) | 43.8 (12.34) |
Median | 43.9 | 43.3 | 43.3 |
Minimum, Maximum | 22.8, 66.4 | 22.2, 62.7 | 22.2, 66.4 |
Gender | |||
Male | 8 (33.3%) | 5 (19.2%) | 13 (26.0%) |
Female | 16 (66.7%) | 21 (80.8%) | 37 (74.0%) |
Ethnicity | |||
Hispanic | 1 (4.2%) | 1 (3.8%) | 2 (4.0%) |
Non-Hispanic | 23 (95.8%) | 25 (96.2%) | 48 (96.0%) |
Race | |||
American Indian or Alaska Native | 0 (0%) | 0 (0%) | 0 (0%) |
Asian | 0 (0%) | 0 (0%) | 0 (0%) |
Black or African American | 0 (0%) | 0 (0%) | 0 (0%) |
Native Hawaiian or Other Pacific Islander | 0 (0%) | 0 (0%) | 0 (0%) |
White | 24 (100.0%) | 25 (96.2%) | 49 (98.0%) |
Other | 0 (0%) | 1 (3.8%) | 1 (2.0%) |